Oleg Krijanovski is a Hematologist in Berkeley, California. Dr. Krijanovski is highly rated in 52 conditions, according to our data. His top areas of expertise are Thrombocytopenia, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration. Dr. Krijanovski is currently accepting new patients.

Uma Suryadevara is a Hematologist in Berkeley, California. Dr. Suryadevara is highly rated in 33 conditions, according to our data. Her top areas of expertise are Paget Disease of the Breast, Inflammatory Breast Cancer, Angiosarcoma, Breast Cancer, and Bone Marrow Aspiration. Dr. Suryadevara is currently accepting new patients.

Kevin Knopf is an Oncologist in Berkeley, California. Dr. Knopf is highly rated in 15 conditions, according to our data. His top areas of expertise are Colorectal Cancer, Prostate Cancer, Pleuropulmonary Blastoma, and Familial Colorectal Cancer. Dr. Knopf is currently accepting new patients.

Elliott Vichinsky is a Hematologist and an Oncologist in Oakland, California. Dr. Vichinsky is highly rated in 14 conditions, according to our data. His top areas of expertise are Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, Splenectomy, and Bone Marrow Transplant.

Ashutosh Lal is a Hematologist and an Oncologist in Oakland, California. Dr. Lal is highly rated in 12 conditions, according to our data. His top areas of expertise are Thalassemia, Beta Thalassemia, Congenital Hemolytic Anemia, Hemoglobinopathy, and Splenectomy.

Mark Walters is a Hematologist and an Oncologist in Oakland, California. Dr. Walters is highly rated in 11 conditions, according to our data. His top areas of expertise are Hemoglobinopathy, Sickle Cell Disease, Congenital Hemolytic Anemia, Hemolytic Anemia, and Bone Marrow Transplant.

Sylvia Singer is a Hematologist and an Oncologist in Oakland, California. Dr. Singer is highly rated in 7 conditions, according to our data. Her top areas of expertise are Thalassemia, Beta Thalassemia, Hemoglobinopathy, Congenital Hemolytic Anemia, and Splenectomy.

Carolyn Hoppe is a Hematologist and an Oncologist in Oakland, California. Dr. Hoppe is highly rated in 6 conditions, according to our data. Her top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia.

Dr. Chienying Liu is an endocrinologist who cares for patients with thyroid cancer, thyroid nodules and other thyroid disorders. She also cares for patients with endocrine neoplasia (tumors of hormone producing glands, such as adrenal tumors, pheochromocytomas, paragangliomas, parathyroid tumors, and pituitary tumors). Liu has research interests in thyroid cancer and adrenal disorders. Liu earned her medical degree from the University of Pittsburgh. She completed a residency in internal medicine at the University of Rochester. She completed her fellowship in diabetes, endocrinology and metabolism at UCSF. Liu is a member of the Endocrine Society and American Thyroid Association. She enjoys teaching medical students, residents and fellows. She received the John Karam MD Clinician Educator Award in 2014. In her free time, Liu enjoys active travel and believes that traveling and seeing the world make us better human beings. Dr. Liu is highly rated in 45 conditions, according to our data. Her top areas of expertise are Thyroid Cancer, Papillary Thyroid Cancer, Medullary Thyroid Carcinoma, Thyroidectomy, and Thymectomy.

Caring, compassionate, and patient centric care. Dr. Quock is highly rated in 30 conditions, according to our data. His top areas of expertise are Small Cell Lung Cancer (SCLC), Thrombocytopenia, Pleuropulmonary Blastoma, Lung Cancer, and Bone Marrow Aspiration.

Dr. Pamela N. Munster is a medical oncologist who cares for patients with breast cancer. Her roles include director of the early-phase clinical trials program for cancer research; co-director of the UCSF Center for BRCA Research; and co-leader of UCSF's program in developmental therapeutics, which focuses on innovative research to find treatments for advanced cancer. In her own research endeavors, Munster is interested in developing new targeted therapies for treatment-resistant cancer. She studies changes in gene expression and resistance to therapy. Her lab is involved in projects evaluating hormone therapies for breast cancer as well as therapies that engage the immune system to fight tumors. She has published in numerous scientific journals and lectured on topics in breast oncology, such as the management of metastatic breast cancer, breast cancer receptors, clinical trials and translational research (the process of applying study findings to patient care). She has a published memoir, “Twisting Fate: My Journey with BRCA – From Breast Cancer Doctor to Patient and Back.” Munster earned her medical degree from the University of Bern in Switzerland. She completed a residency in internal medicine at Indiana University Health, followed by a fellowship in medical hematology and oncology at Memorial Sloan Kettering Cancer Center, where she also served as faculty in the breast cancer program. Prior to joining UCSF, Munster worked for six years in the Moffitt Cancer Center's division of breast oncology and experimental therapeutics program, serving as scientific director of breast research and co-chair of the phase 1 clinical trial program. Dr. Munster is highly rated in 29 conditions, according to our data. Her top areas of expertise are Breast Cancer, HER2 Negative Breast Cancer, Li-Fraumeni Syndrome, Prostatectomy, and Liver Embolization.

Dr. Maxwell Meng is a surgeon specializing in urologic cancers and laparoscopy. His interests in patient care include diagnosing and managing cancers of the genital and urinary organs, as well as minimally invasive treatments of both benign and malignant diseases. He is experienced in robotic surgery. Meng is active in research to develop new treatment technologies. Meng earned his medical degree at Johns Hopkins School of Medicine. He completed general surgery and urology training at UCSF, where he also completed fellowships in urologic oncology and minimally invasive surgery. Dr. Meng is highly rated in 28 conditions, according to our data. His top areas of expertise are Bladder Cancer, Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Reconstructive Urology Surgery.

Dr. Alain Algazi is a specialist in medical treatment – such as chemotherapy and immunotherapy – for patients with head and neck cancers, including head and neck squamous cell carcinoma, thyroid cancers and salivary gland cancers. He leads UCSF's program in medical therapy for head and neck cancers, and chairs the head and neck cancer research committee. In research, Algazi conducts clinical trials – studies that evaluate new therapies for head and neck cancers with an emphasis on approaches to improving the chances of long term remission in patients with incurable cancer using immunotherapy. He has also served the national study chair for clinical trials that give patients access to new medications and that provide new approaches of administering existing medications to improve their efficacy. Algazi earned his medical degree from the David Geffen School of Medicine at UCLA and completed a residency in internal medicine at Ronald Reagan UCLA Medical Center. He completed a fellowship in hematology-oncology at UCSF. Algazi is a member of the American Society of Clinical Oncology, Society for Immunotherapy for Cancer and American Association for Cancer Research. To reach Dr. Alain Algazi, please contact the head and neck medical oncology practice at (415) 353-9900. Dr. Algazi is highly rated in 25 conditions, according to our data. His top areas of expertise are Melanoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Polymorphous Low Grade Adenocarcinoma, and Glioma.

Dr. Sanziana Roman is an endocrine surgeon with two decades of experience in treating tumors of the adrenal, thyroid and parathyroid glands. With a particular interest in minimally invasive techniques, she is one of the few surgeons in the world to frequently perform posterior retroperitoneoscopic adrenalectomy, a recently developed way of removing adrenal glands through the back that has advantages over the more common frontal approach. Roman has extensive experience in treating thyroid growths in children and adolescents, as well as in adults. She sees patients with conditions including goiter, Graves' disease, thyroid cancer and congenital hypothyroidism with goiter. She also has expertise in inherited syndromes such as multiple endocrine neoplasia, a group of rare disorders in which the endocrine glands develop tumors. Roman earned her medical degree at Columbia University Vagelos College of Physicians and Surgeons. She completed a residency in general surgery at Yale School of Medicine. Prior to joining UCSF, she was chief of endocrine surgery at Yale for 13 years and later served on the faculty of Duke University for more than five years, becoming a tenured professor of surgery. She was also associate chief of Duke's advanced oncological and gastrointestinal surgery division. She established Duke's centers for adrenal disease and pediatric thyroid disease. Roman has been listed in America's Top Doctors . Her research has been published in numerous medical journals, including JAMA Surgery, Annals of Surgery and Thyroid. She is a fellow of the American College of Surgeons and belongs to the American Association of Endocrine Surgeons, International Association of Endocrine Surgeons, American Thyroid Association, Endocrine Society, Society of University Surgeons and American Surgical Association. Prior to becoming a surgeon, Roman was an opera singer. Her love of singing and surgery have combined into a passion for using her skills to save the voices of patients undergoing neck operations. Dr. Roman is highly rated in 23 conditions, according to our data. Her top areas of expertise are Thyroid Cancer, Hyperparathyroidism, Parathyroid Hyperplasia, Thyroidectomy, and Parathyroidectomy.

Alan Kramer is an Oncologist in San Francisco, California. Dr. Kramer is highly rated in 22 conditions, according to our data. His top areas of expertise are Nasopharyngeal Carcinoma, Angiosarcoma, Paget Disease of the Breast, and Breast Cancer. Dr. Kramer is currently accepting new patients.

Dr. Sima Porten is a specialist in cancers of the genital and urinary organs. She is a member of the urologic oncology team at the UCSF Helen Diller Family Comprehensive Cancer Center. Her clinical interests include the diagnosis and treatment of genitourinary cancer, particularly bladder cancer, upper tract urothelial cancer, kidney cancer and high-risk prostate cancer. Porten's research focuses mainly on the diagnosis and management of urothelial carcinoma, a cancer involving parts of the kidney, bladder and ureter (the tube connecting each kidney to the bladder). In studying the biologic or genetic basis of urothelial carcinoma, she hopes to develop new tests and treatments to bring personalized medicine to patients with bladder cancer. Porten received her undergraduate, medical and master of public health degrees from Northwestern University. During medical school, she was inducted into the Alpha Omega Alpha Honor Medical Society and also completed a fellowship through the Howard Hughes Medical Institute–National Institutes of Health Research Scholars Program. She then completed her urology residency training at UCSF, where she received the Julius R. Krevans Award for Clinical Excellence. During her training in urologic oncology at the University of Texas MD Anderson Cancer Center, she was awarded a John Quale Travel Fellowship for her research in bladder cancer. Porten is an active member of the American Urological Association, American Society of Clinical Oncology, Society of Women in Urology and Society of Urologic Oncology. Dr. Porten is highly rated in 20 conditions, according to our data. Her top areas of expertise are Bladder Cancer, Urothelial Cancer, Non-Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy.

Dr. Andrew H. Ko is a specialist in digestive system cancers. He provides compassionate and individualized care for patients with cancers of the pancreas, stomach and esophagus. In research, Ko has long been active in developing and evaluating new treatments for gastrointestinal cancers, including molecularly targeted agents and immune-based therapies. Ko earned an undergraduate degree in applied mathematics and biology at Brown University. He earned his medical degree at the Johns Hopkins University School of Medicine. He completed a residency in internal medicine at Beth Israel Deaconess Medical Center, an affiliate of Harvard Medical School, and completed a fellowship in medical oncology at Stanford University. He joined UCSF in 2001. Dr. Ko is highly rated in 20 conditions, according to our data. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Stomach Cancer, Pancreaticoduodenectomy, and Pancreatectomy.

John Chan is an Oncologist and an Obstetrics and Gynecologist in San Francisco, California. Dr. Chan is highly rated in 18 conditions, according to our data. His top areas of expertise are Adult Soft Tissue Sarcoma, Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, Oophorectomy, and Bladder Reconstruction. Dr. Chan is currently accepting new patients.

Stephanie Jeske is an Oncologist in San Francisco, California. Dr. Jeske is highly rated in 18 conditions, according to our data. Her top areas of expertise are Angiosarcoma, Paget Disease of the Breast, Breast Cancer, and Inflammatory Breast Cancer. Dr. Jeske is currently accepting new patients.

Dr. Julie Ann Sosa is an endocrine surgeon who specializes in thyroid cancer. She also has expertise in treating adults and children for a variety of benign and malignant endocrine conditions of the thyroid, parathyroid and adrenal glands. She chairs the UCSF Department of Surgery. Sosa's research focuses on developing treatments for advanced thyroid cancer and understanding environmental factors that can raise a person's risk for the disease. She also has published extensively on predictors of optimal patient outcomes following a variety of cancer-based procedures. Sosa earned her medical degree at Johns Hopkins University School of Medicine, where she also completed the Halsted residency in general surgery and served as chief resident. She completed a fellowship in clinical research with the Robert Wood Johnson Foundation at Johns Hopkins, where she was also assistant chief of service and an instructor. She has a master's degree in human sciences from the University of Oxford. Prior to joining UCSF, she was chief of endocrine surgery at Duke University, and held leadership positions at the Duke Cancer Institute and Duke Clinical Research Institute. Sosa is a fellow of the American College of Surgeons. She is the elected editor-in-chief of the World Journal of Surgery, and had previous positions as deputy editor of JAMA Surgery and associate editor of the Journal of Surgical Research. She serves on the editorial boards of seven medical journals, including the Annals of Surgery, Surgery, Annals of Surgical Oncology, Endocrine and International Journal of Endocrine Oncology. She serves on the boards of the Society of Surgical Oncology, International Thyroid Oncology Group, Association for Academic Surgery Foundation and American Thyroid Association, where she is also treasurer. She is the Leon Goldman, MD Distinguished Professor of Surgery at UCSF. Sosa was born in Montréal and raised in upstate New York. Dr. Sosa is highly rated in 18 conditions, according to our data. Her top areas of expertise are Thyroid Cancer, Parathyroid Hyperplasia, Papillary Thyroid Cancer, Thyroidectomy, and Parathyroidectomy.

Gauri Kelekar is an Oncologist in San Francisco, California. Dr. Kelekar has been practicing medicine for over 18 years is highly rated in 16 conditions, according to our data. Her top areas of expertise are Familial Pancreatic Cancer, Familial Colorectal Cancer, Urothelial Cancer, and Fibrolamellar Carcinoma. Dr. Kelekar is currently accepting new patients.

Dr. Matthew Gubens is a thoracic oncologist who cares for patients with lung cancer. He specializes particularly in treating non-small cell lung cancer, small cell lung cancer, thymoma and thymic carcinoma, and mesothelioma. In his research, Gubens studies new treatment strategies for lung cancer and other malignancies of the chest area. Gubens earned his medical degree at Stanford University School of Medicine. He completed a residency in internal medicine at UCSF and a fellowship in medical oncology at Stanford. He also earned a master's degree in health policy and management at the Harvard T.H. Chan School of Public Health. Gubens is a member of the American Society of Clinical Oncology, International Association for the Study of Lung Cancer and International Thymic Malignancy Interest Group. Dr. Gubens is highly rated in 16 conditions, according to our data. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Thymic Epithelial Tumor, and Lung Adenocarcinoma.

Dr. Emily Bergsland is a gastrointestinal oncologist at the UCSF Helen Diller Family Comprehensive Cancer Center and the director of the UCSF Center for Neuroendocrine Tumors. She specializes in the multidisciplinary care of patients with neuroendocrine cancers. Bergsland's research is focused on better understanding why neuroendocrine tumors develop, identifying and testing new therapies, and improving outcomes in affected patients. Bergsland earned her medical degree at the University of Minnesota, then completed a residency in internal medicine and fellowship in medical oncology at UCSF. Dr. Bergsland is highly rated in 15 conditions, according to our data. Her top areas of expertise are Neuroendocrine Tumor, Carcinoid Syndrome, Pancreatic Islet Cell Tumor, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), and Hepatectomy.

Rajesh Behl is an Oncologist in Berkeley, California. Dr. Behl is highly rated in 64 conditions, according to our data. His top areas of expertise are Waldenstrom Macroglobulinemia, Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), Multiple Myeloma, and Bone Marrow Aspiration.

Dr. Vadim S. Koshkin is a genitourinary oncologist who specializes in caring for adults with bladder, prostate, kidney and testicular cancers. His personal enthusiasm for travel informs his approach to care, as he likes to hear about where his patients come from in order to better understand who they are. In his research, Koshkin designs and carries out clinical trials of treatments for bladder and prostate cancers. He has a particular focus on the role of immunotherapy, or treatments that stimulate a patient's own immune system to help fight cancer. He also studies targeted treatments that are aimed against specific mutations in the DNA of tumor cells, which make these tumors more vulnerable to particular drugs. This allows for the delivery of personalized treatment based on individual characteristics of patients and their tumors. After earning his medical degree at the University of Chicago Pritzker School of Medicine, Koshkin completed a residency in internal medicine at the University of Michigan. He then completed a fellowship in hematology and oncology at the Cleveland Clinic. He belongs to the American Society of Clinical Oncology, American Association for Cancer Research and Bladder Cancer Advocacy Network. A history and trivia buff, Koshkin loves to read. He also follows soccer and Chicago sports teams in his free time. Dr. Koshkin is highly rated in 14 conditions, according to our data. His top areas of expertise are Urothelial Cancer, Bladder Cancer, Renal Cell Carcinoma (RCC), Non-Muscle Invasive Bladder Cancer, and Lymphadenectomy.